1 |
Korean Institute for Health and Social Affairs. Prevalence of asthma like symptoms in Korean adult population. Korean J Med 2001;60:196-205.
|
2 |
Global Asthma Network. The global asthma report 2014 [Internet]. Global Asthma Network; 2014 [cited 2017 Dec 29]. Available from: http://www.globalasthmareport.org/burden/mortality.php.
|
3 |
Barnes PJ. New drugs for asthma. Semin Respir Crit Care Med 2012;33:685-94.
DOI
|
4 |
Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332-6.
DOI
|
5 |
Global Initiative for Asthma. Global strategy for the diagnosis and prevention [Internet]. Global Initiative for Asthma; 2017 [cited 2017 Dec 29]. Available from: https://ginasthma.org/.
|
6 |
Kim DK, Park YB, Oh YM, Jung KS, Yoo JH, Yoo KH, et al. Korean asthma guideline 2014: summary of major updates to the Korean asthma guideline 2014. Tuberc Respir Dis 2016;79:111-20.
DOI
|
7 |
Brode SK, Campitelli MA, Kwong JC, Lu H, Marchand-Austin A, Gershon AS, et al. The risk of mycobacterial infections associated with inhaled corticosteroid use. Eur Respir J 2017;50:1700037.
DOI
|
8 |
Lee CH, Kim K, Hyun MK, Jang EJ, Lee NR, Yim JJ. Use of inhaled corticosteroids and the risk of tuberculosis. Thorax 2013;68:1105-13.
DOI
|
9 |
Qian CJ, Coulombe J, Suissa S, Ernst P. Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort study. Br J Clin Pharmacol 2017;83:2077-86.
DOI
|
10 |
Smeeth L, Boulis M, Hubbard R, Fletcher AE. A population based case-control study of cataract and inhaled corticosteroids. Br J Ophthalmol 2003;87:1247-51.
DOI
|
11 |
Hanania NA, Chapman KR, Sturtridge WC, Szalai JP, Kesten S. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995;96(5 Pt 1):571-9.
DOI
|
12 |
Zhang L, Prietsch SO, Ducharme FM. Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database Syst Rev 2014;(7):CD009471.
|
13 |
van Noord JA, Smeets JJ, Maesen FP. A comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction. Respir Med 1998;92:1346-51.
DOI
|
14 |
Beasley R, Weatherall M, Shirtcliffe P, Hancox R, Reddel HK. Combination corticosteroid/beta-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma? J Allergy Clin Immunol 2014;133:39-41.
DOI
|
15 |
Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet 1989;1:917-22.
|
16 |
Suissa S, Ernst P, Boivin JF, Horwitz RI, Habbick B, Cockroft D, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 1994;149(3 Pt 1):604-10.
DOI
|
17 |
Suissa S, Hemmelgarn B, Blais L, Ernst P. Bronchodilators and acute cardiac death. Am J Respir Crit Care Med 1996;154(6 Pt 1):1598-602.
DOI
|
18 |
O'Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? Eur Respir J 2017;50:1701103.
DOI
|